①Letters in Drug Design & Discovery的影响因子较平稳,2023年最新影响因子为1。 ②Letters in Drug Design & Discovery的自引率总体不高,2023年度为10%。 ③Letters in Drug Design & Discovery最近五年发文量分别为136,137,137,95,87。 近期想要快速发表文章的同学可以添加佩普科研助理咨询,佩普学术是专门为科研...
总的来说,Letters in Drug Design & Discovery在医药化学领域中影响力和排名适中,影响因子为1.2,年发文量为87篇,审稿速度平均3.0月,2023年国人文章占比24.5%,投稿难度属于较低级别。
Letters in Drug Design & Discovery《药物研制快报》 (官网投稿) 简介 期刊简称LETT DRUG DES DISCOV 参考译名《药物研制快报》 核心类别 SCIE(2024版), 目次收录(维普), 知网外文库,外文期刊, IF影响因子 自引率 主要研究方向医学-CHEMISTRY, MEDICINAL药物化学 Letters in Drug Design & Discovery《药物研制...
《药物设计与发现快报》(Letters In Drug Design & Discovery)是一本以医学-医药化学综合研究为特色的国际期刊。该刊由Bentham Science Publishers B.V.出版商创刊于2004年,刊期Bimonthly。该刊已被国际重要权威数据库SCIE收录。期刊聚焦医学-医药化学领域的重点研究和前沿进展,及时刊载和报道该领域的研究成果,致力于成...
《Letters In Drug Design & Discovery》(《药物设计与发现快报》)是一本由Bentham Science Publishers B.V.出版的医学-医药化学学术刊物,主要刊载医学-医药化学相关领域研究成果与实践,旨在打造一种学术水平高、可读性强、具有全球影响力的学术期刊。本刊已入选SCIE来源期刊。该刊创刊于2004年,出版周期Bimonthly。2023...
Letters in Drug Design & DiscoveryCAPubMedAJSCIE中科院4区JCR:Q4 发文量2,655 被引量13,174 影响因子(2023)1.277 Aims & Scope Letters in Drug Design & Discovery publishes letters, mini-reviews, highlights and guest edited thematic issues in all areas of rational drug design and discovery including...
Letters In Drug Design & Discovery创刊于2004年,由Bentham Science Publishers B.V.出版商出版,收稿方向涵盖医学 - 医药化学全领域,此期刊水平偏中等偏靠后,在所属细分领域中专业影响力一般,过审相对较易,如果您文章质量佳,选择此期刊,发表机率较高。平均审稿速度 约3.0个月 ,影响因子指数1.2,该期刊近期没有被...
Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, research articles, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug...
and the Anti-Adhesive Properties of Gracilin B, Synthesis and Biochemical Evaluation of a Range of Non-Substituted Phenyl Alkyl Triazole-Based Compounds as Potential Inhibitors of the Enzyme Complex 17伪 -Hydroxylase/17,20-Lyase (P45017伪),Letters in Drug Design & Discovery, 1570-1808, 1875-628...
Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, research articles, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug...